Searchable abstracts of presentations at key conferences in endocrinology

ea0030oc2.4 | Oral Communications 2 | BSPED2012

Prenatal dexamethasone for treatment of congenital adrenal hyperplasia: a possible association with late gestational fetal demise in two cases

Peacock Amanda , Abbey Ianthe , Alvi Sabah , Bennett Chris , Dwyer James , Glanville Tracey , Mushtaq Talat

Introduction: The prenatal treatment of Congenital Adrenal Hyperplasia (CAH) with Dexamethasone (Dex) is effective at minimising virilisation in affected females. Treatment is initiated with Dex at 20 mcg/kg per day (max 1.5 mg/day) as soon as pregnancy is confirmed and continued to term in affected females only. There are concerns regarding neurocognitive difficulties in children exposed to prenatal Dex, but no reports of late intra-uterine deaths (IUD) attributed to prenatal...